LFWD Market Analysis
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—
EPS (TTM)$-18.330.0% YoY
Profit margin-123.7%HEALTHCARE
Market cap$20.3MMicro cap
Valuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 3.23
- P/S (TTM)
- 0.97
- EV/EBITDA
- 1.03
Profitability & growth
- ROE (TTM)
- -209.1%
- Operating margin
- -123.4%
- Revenue growth YoY
- -22.1%
- Dividend yield
- —
- Beta
- 0.37
Last earnings
May 15, 2026 · Estimate $-0.34 · Reported $-6.70
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About ReWalk Robotics Ltd
Company profileReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company is headquartered in Yokneam Illit, Israel.
Classification
- Sector
- Healthcare
- Industry
- Medical Devices
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 3 HATNUFA ST., YOKNEAM ILLIT, ISRAEL
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$20.3M
Shares outstanding$2.8M
52W high$10.56
52W low$4.14
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent